跳至主要内容
临床试验/NCT03540459
NCT03540459Unknown不适用

Central Apnea in Patients Receiving Ticagrelor

Les Grands Prés1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2018年4月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
50
试验地点
1
主要终点
central apnea index

研究概览

简要总结

all patients with a left ventricular ejection fraction superior or equal to 50% less than 2 years after an acute coronary event and receiving ticagrelor will undergo a sleep polygraphy

详细描述

all patients with a left ventricular ejection fraction superior or equal to 50% less than 2 years after an acute coronary event and receiving ticagrelor will undergo a sleep polygraphy the main objective of the study will be to look for central sleep apnea

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •patient receiving ticagrelor 10 days to 2 years after an acute coronary syndrome

排除标准

  • •left ventricular ejection fraction < 50%
  • •patients refusal

结局指标

主要结局

central apnea index

时间窗: at baseline

mean central apnea index: apnea hypopnea index (AHI) is the scale commonly used to assess sleep disordered breathing.This scale includes central and obstructive apnea and hypopnea. The main outcome will be the central apnea index: number of central apnea per hour

次要结局

  • global apnea hypopnea index(baseline)

研究者

发起方
Les Grands Prés
申办方类型
Other
责任方
Principal Investigator
主要研究者

philippe meurin

principal investigator

Les Grands Prés

研究点 (1)

Loading locations...

相似试验